Custom Search


Portfolio of Biotech Stocks: Arthritis

Here is a sample of 4 biotech stocks that provide arthritis treatments.

Biotech Stocks: Arthritis
Stock
Price Quote & Dividend
Recent Dividends
1-Yr Price Chart
Amgen
Antares Pharma
Horizon Pharma plc
Incyte Corporation
Price and dividend data from Quandl.


To inspect the performance of the Biotech Stocks: Arthritis portfolio, see the returns table and chart below. Portfolio values are computed using quarterly closes from Quandl.

The 3 stocks included in the portfolio computations are: AMGN, ATRS and INCY. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each at its closing quarterly price for the current date in 2007. HZNP was excluded from the portfolio computations because prices started after 2007.


Biotech Stocks: Arthritis - Return Results
Portfolio:
Biotech Stocks: Arthritis
Start date:
Aug-17-2007
Start value:
$10,000
End date:
Aug-17-2017
End value:
$76,599
Number prices
41
Minimum value occurred on Mar-31-2009
$5,018
Maximum value occurred on Mar-31-2017
$79,881
Total gain or loss (Start date to End date)
665.99%
Annualized gain or loss (Start date to End date)
21.97%
Total dollar value on End date of a $10,000 purchase made on Start date
$76,599
Average percent return for all possible buy/sell combinations
203.20%
Number returns
820
Number profitable returns (Winners)
722
Percent profitable returns
88.05%
Number unprofitable returns (Losers)
98
Percent unprofitable returns
11.95%
Winners to losers ratio
7.37
See Multiyear Chart of Monthly Portfolio Values


Related Articles

Portfolio of Big Pharmaceuticals Stocks: Arthritis
Portfolio of Biotech Stocks
Portfolio of Biotech Stocks: Cancer
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Generic Drug Stocks